Takeda Pharmaceutical Company Ltd
🇸🇪Sweden
- Country
- 🇸🇪Sweden
- Ownership
- -
- Established
- 1925-01-01
- Employees
- -
- Market Cap
- $47.5B
- Website
- http://www.takeda.co.jp/
A Study of TAK-279 in Healthy Adults on the Effect on ECG Measurements
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- First Posted Date
- 2024-02-14
- Last Posted Date
- 2024-07-11
- Lead Sponsor
- Takeda
- Target Recruit Count
- 120
- Registration Number
- NCT06258265
- Locations
- 🇺🇸
Celerion, Tempe, Arizona, United States
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis
Phase 2
Recruiting
- Conditions
- Ulcerative Colitis
- Interventions
- Drug: TAK-279Drug: Placebo
- First Posted Date
- 2024-02-12
- Last Posted Date
- 2025-01-03
- Lead Sponsor
- Takeda
- Target Recruit Count
- 207
- Registration Number
- NCT06254950
- Locations
- 🇺🇸
GastroIntestinal BioSciences, Los Angeles, California, United States
🇺🇸United Medical Doctors, Murrieta, California, United States
🇺🇸UCI Health, Orange, California, United States
A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation
Not yet recruiting
- Conditions
- Cytomegalovirus (CMV)Kidney FailureKidney Disease
- Interventions
- Other: No Intervention
- First Posted Date
- 2024-02-06
- Last Posted Date
- 2024-05-03
- Lead Sponsor
- Takeda
- Target Recruit Count
- 10
- Registration Number
- NCT06243731
A First-In-Human Study of TAK-004 in Healthy Adults
Phase 1
Recruiting
- Conditions
- Healthy Volunteers
- Interventions
- Drug: TAK-004Drug: Placebo
- First Posted Date
- 2024-02-01
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- Takeda
- Target Recruit Count
- 240
- Registration Number
- NCT06236009
- Locations
- 🇺🇸
Celerion, Tempe, Arizona, United States
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Phase 2
Recruiting
- Conditions
- Crohn's Disease
- Interventions
- Drug: TAK-279Drug: Placebo
- First Posted Date
- 2024-01-31
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Takeda
- Target Recruit Count
- 268
- Registration Number
- NCT06233461
- Locations
- 🇺🇸
GastroIntestinal BioSciences, Los Angeles, California, United States
🇺🇸United Medical Doctors, Murrieta, California, United States
🇺🇸UCI Health, Orange, California, United States
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
Phase 3
Not yet recruiting
- Conditions
- Crohn's Disease
- Interventions
- First Posted Date
- 2024-01-29
- Last Posted Date
- 2024-08-13
- Lead Sponsor
- Takeda
- Target Recruit Count
- 396
- Registration Number
- NCT06227910
A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection in Argentina
Recruiting
- Conditions
- Cytomegalovirus (CMV)
- Interventions
- Other: No Intervention
- First Posted Date
- 2024-01-19
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- Takeda
- Target Recruit Count
- 10
- Registration Number
- NCT06213974
- Locations
- 🇦🇷
IC Projects, City of Buenos Aires, Argentina
Expanded Access to TAK-113 for Adults With Metastatic Colorectal Cancer (mCRC)
- Conditions
- Colorectal Cancer
- First Posted Date
- 2024-01-08
- Last Posted Date
- 2024-04-04
- Lead Sponsor
- Takeda
- Registration Number
- NCT06195514
Post Trial Access Program of TAK-577 for Von Willebrand Disease (VWD)
- Conditions
- Von Willebrand Disease (VWD)
- First Posted Date
- 2023-12-15
- Last Posted Date
- 2024-01-05
- Lead Sponsor
- Takeda
- Registration Number
- NCT06173024
Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)
Phase 3
Recruiting
- Conditions
- Alpha1-Antitrypsin Deficiency
- Interventions
- Drug: Fazirsiran InjectionDrug: Placebo
- First Posted Date
- 2023-12-11
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- Takeda
- Target Recruit Count
- 50
- Registration Number
- NCT06165341
- Locations
- 🇺🇸
University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
🇺🇸St Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
🇺🇸Mayo Clinic - PPDS, Phoenix, Arizona, United States
© Copyright 2025. All Rights Reserved by MedPath